|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$314,247
|
$314,247
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$104,749
|
$104,749
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$69,833
|
$69,833
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$139,666
|
$139,666
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigentic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$34,916
|
$34,916
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$34,916
|
$34,916
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$76,885
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$372,283
|
$372,283
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$558,424
|
$558,424
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$460,324
|
$460,324
|
Barchi, Joseph
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$113,744
|
$28,436
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$170,616
|
$34,123
|
Bates, Susan
|
CCR (NCI)
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$10,042
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$189,189
|
$56,757
|
Beutler, John
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$104,794
|
$104,794
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$78,595
|
$7,860
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$340,579
|
$170,290
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$361,814
|
$253,270
|
Buck, Christopher
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,104,439
|
$110,444
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$311,063
|
$155,532
|
Citrin, Deborah
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$806,358
|
$161,272
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$57,943
|
$28,971
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,429,508
|
$428,852
|
Edelman, Daniel
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$344,293
|
$34,429
|
Figg, William
|
CCR (NCI)
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$412,674
|
$206,337
|
Fojo, Antonio
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$263,739
|
$52,748
|
Fowler, Daniel
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$504,068
|
$50,407
|
Garfield, Susan
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$290,767
|
$5,815
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$872,302
|
$43,615
|
Gottesman, Michael
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,389,288
|
$658,393
|
Gulley, James
|
CCR (NCI)
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$84,603
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,735,022
|
$173,502
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$822,004
|
$328,802
|
Hou, Steven
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$294,411
|
$14,721
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$376,957
|
$7,539
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$539,792
|
$26,990
|
Khan, Javed
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,032,939
|
$51,647
|
Kleiner, David
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$15,841
|
$7,920
|
Kong, Heidi
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$234,356
|
$46,871
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,773
|
$386,830
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,031,546
|
$773,659
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,031,546
|
$1,021,230
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$773,659
|
$464,195
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,805,205
|
$1,444,164
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$261,567
|
$26,157
|
Mackem, Susan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$639,870
|
$127,974
|
Meier, Jordan
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$171,153
|
$102,692
|
Merino, Maria
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$114,102
|
$114,102
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$171,153
|
$80,442
|
Merino, Maria
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $15,915,650
|